Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu -9-MTH group results

Jan 13 (Reuters)-  
             Hisamitsu Pharmaceutical Co Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Nov 30, 2016        Nov 30, 2015     Feb 28, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              109.73              122.28           155.00     
                   (-10.3 pct)         (+6.4 pct)       (-4.2 pct)   
  Operating           22.00               23.32            28.00     
                   (-5.7 pct)          (+49.2 pct)      (+1.0 pct)   
  Recurring           22.89               23.47            29.00     
                   (-2.5 pct)          (+3.7 pct)       (+3.5 pct)   
  Net                 18.34               15.32            19.40     
                   (+19.7 pct)         (+5.8 pct)       (+9.1 pct)   
  EPS              216.23 yen          179.51 yen       228.72 yen   
  EPS Diluted      216.12 yen          179.49 yen                    
  Ann Div                               81.00 yen        81.00 yen   
  -Q2 div           40.50 yen           40.00 yen                    
  -Q4 div                               41.00 yen        40.50 yen   
   
  NOTE - Hisamitsu Pharmaceutical Co Inc.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Hisamitsu Pharmaceutical Co

See all news